|
Genentech's clinical trials are crucial to the exploration of new therapies that may address significant unmet medical needs. Genentech places a high priority on communicating information about studies that are currently enrolling as well as on ensuring that clinical trial results for completed studies for marketed products are available to physicians and other interested parties.
To learn more about access to Genentech's investigational therapies, please read our policy statement on access. Clinical Trial Enrollment Genentech posts protocol information for all ongoing Phase II, III, and IV Genentech-sponsored trials to the National Institutes of Health's (NIH) ClinicalTrials.gov website. To learn more about the Genentech clinical trials that are under way or to find out if a study is enrolling patients in your area, please visit www.clinicaltrials.gov. To help you find the information you need, Genentech has prepared a "Guide to Browsing Genentech Studies That Are Open for Enrollment." Clinical Trial Results Genentech posts summaries of clinical trial results for all Genentech-sponsored Phase II, III, and IV clinical trials completed after October 15, 2002 for all of our marketed products. To learn more about clinical trial results for completed Genentech clinical trials, please visit www.clinicaltrials.gov. To help you navigate to the trial results for a particular study, Genentech has prepared a "Guide to Accessing Genentech's Clinical Trial Study Results." Collaborators Genentech collaborates with several other pharmaceutical and biotechnology companies in the development of its products. To learn more about our collaborators' clinical trials, we have provided contact information on the development pipeline product pages. |
